Featured Post

Latest Gold News

Economic power could shift further East with Hong Kong gold exchange Russian investment bank sees $1,400 gold by end of 2017 Weak CPI...

Tuesday, December 20, 2011

ResMed (RMD) (CCI) (CELL) (MDT) (MS) (TKLC) Ratings, Price Targets

ResMed Inc. (NYSE: RMD), Crown Castle (NYSE: CCI), Brightpoint Inc. (NASDAQ: CELL), Medtronic, Inc. (NYSE: MDT), Morgan Stanley (NYSE: MS) and Tekelec (NASDAQ: TKLC) ratings and price targets.

Zacks Investment Research reiterated its "Neutral" rating on Crown Castle (CCI). They have a price target of $45.00 on the company.

Canaccord Genuity reiterated its "Buy" rating on Brightpoint Inc. (CELL).

Susquehanna initiated coverage on Medtronic, Inc. (MDT). They have a “Neutral” rating and a price target of $40.00 on the company.

Evercore Partners initiated coverage on Morgan Stanley (MS). They have an “Equal Weight” rating on the company.

Tekelec (TKLC) was downgraded by Sidoti from a “Buy” rating to a “Neutral” rating.

ResMed Inc. (RMD) was upgraded by Feltl & Co from a “Buy” rating to a “Strong Buy” rating. They have a price target of $35.00 on the company.

No comments: